1 – 10 of 28
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Parental longevity and survival among patients with multiple myeloma and monoclonal gammopathy of undetermined significance : a population-based study
- Contribution to journal › Article
- 2015
-
Mark
Population-based study on the impact of the familial form of Waldenström macroglobulinemia on overall survival.
- Contribution to journal › Letter
- 2014
-
Mark
Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in Sweden.
- Contribution to journal › Article
- 2012
-
Mark
Familial Aggregation of Lymphoplasmacytic Lymphoma/Waldenstrom Macroglobulinemia with Solid Tumors and Myeloid Malignancies
- Contribution to journal › Scientific review
-
Mark
Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study
- Contribution to journal › Article
- 2011
-
Mark
Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS)
- Contribution to journal › Article
-
Mark
Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study
- Contribution to journal › Article
- 2010
-
Mark
Immune-Related and Inflammatory Conditions and Risk of Lymphoplasmacytic Lymphoma or Waldenstrom Macroglobulinemia.
- Contribution to journal › Article
-
Mark
Monoclonal Gammopathy of Undetermined Significance and Risk of Infections A Population Based Study
(2010) 52nd Annual Meeting of the American-Society-of-Hematology (ASH) In Blood 116(21). p.1652-1652
- Contribution to journal › Published meeting abstract
-
Mark
Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study
- Contribution to journal › Article